a developer of novel immunotherapy biologic agents
Industry Biotechnology
A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with PGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then PGEN could also see price increases.
Ticker / NAME | Correlation To FBIO | 1D Price Change % | ||
---|---|---|---|---|
FBIO | 100% | -4.85% | ||
PGEN - FBIO | 38% Loosely correlated | -3.58% | ||
NTLA - FBIO | 38% Loosely correlated | -6.15% | ||
BEAM - FBIO | 36% Loosely correlated | -4.33% | ||
EDIT - FBIO | 35% Loosely correlated | -6.42% | ||
SEER - FBIO | 35% Loosely correlated | +4.76% | ||
More |
Ticker / NAME | Correlation To FBIO | 1D Price Change % |
---|---|---|
FBIO | 100% | -4.85% |
drugs theme (254 stocks) | 32% Poorly correlated | -1.67% |
biotechnology theme (238 stocks) | 28% Poorly correlated | -1.76% |
immunotherapy theme (12 stocks) | 16% Poorly correlated | -6.14% |
biological theme (25 stocks) | 14% Poorly correlated | -1.51% |